P3H2抗体;P3H2 Antibody—艾普蒂 新品

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human tonsil tissue using P13372(P3H2 Antibody) at dilution 1/35. (Original magnification: ×200)    

  
  

The P3H2 antibody targets prolyl 3-hydroxylase 2 (P3H2), an enzyme belonging to the prolyl hydroxylase family involved in collagen biosynthesis. P3H2. encoded by the *LEPRE1* gene, catalyzes the post-translational 3-hydroxylation of specific proline residues in collagen chains, a critical modification for collagen folding, stability, and fibrillogenesis. It primarily acts on type I, II, IV, and V collagens, which are essential components of connective tissues, cartilage, and basement membranes.

Research on P3H2 gained momentum due to its association with osteogenesis imperfecta (OI) and other connective tissue disorders. Mutations in *LEPRE1* disrupt collagen hydroxylation, leading to abnormal fibril formation and tissue fragility. Antibodies against P3H2 are pivotal in studying collagen maturation pathways, protein-protein interactions (e.g., with CRTAP and cyclophilin B in the collagen-modifying complex), and disease mechanisms. They enable detection of P3H2 expression in tissues, assessment of its localization, and evaluation of its role in pathological conditions.

Recent studies also explore P3H2's potential in regenerative medicine, particularly in bone and cartilage repair. The antibody serves as a tool to investigate therapeutic strategies targeting collagen modifications, such as small molecule inhibitors or gene therapies. Its development underscores the growing interest in collagen biology and extracellular matrix-related diseases, bridging fundamental research with clinical applications.